Stock HGENQ HUMANIGEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Humanigen, Inc.

Equities

HGENQ

US4448632038

Market Closed - OTC Markets
Other stock markets
 12:06:11 02/05/2024 am IST 		5-day change 1st Jan Change
0.0002 USD 0.00% Intraday chart for Humanigen, Inc. 0.00% -83.33%
12/04 Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. CI
08/03 Final DIP Financing Approved for Humanigen, Inc. CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CapitalGainesReport: OTC Bounce List (EPAZ, ABML, HGEN, RINO)
AQ
Exploring Breakthrough Biotech Stocks: ENZC, CYDY, HGEN, HALB
AQ
HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
AQ
HUMANIGEN, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
HUMANIGEN, INC : Regulation FD Disclosure (form 8-K)
AQ
HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
HUMANIGEN, INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
HUMANIGEN, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
AQ
HUMANIGEN, INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
HUMANIGEN, INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
AQ
Humanigen : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
HUMANIGEN, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Humanigen Reports Second Quarter 2022 Financial Results
BU
HUMANIGEN, INC : Termination of a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Humanigen : receives preliminary topline data from NIH/NIAID study of lenzilumab in ACTIV-5/BET-B - Form 8-K
PU
HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HGENQ Stock
  4. News Humanigen, Inc.
  5. Press Releases